Experience

Startup sold to major drug company based on strength of patents

Agouron Pharmaceuticals, Inc.

Finnegan successfully generated patents to cover protease inhibitor Viracept®, for then startup company Agouron Pharmaceuticals, Inc. Agouron was ultimately acquired by Warner-Lambert (now part of Pfizer) based on the strength of the Viracept® patents, for $2.1 billion.

Tags

pharma patent strategy

Related Practices

Diligence, Licensing, and Opinions

Opinions and Counseling

Prosecution and Portfolio Management

Patent Drafting and Prosecution

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Represented a UK-based innovative diagnostics company, in a patent litigation relating to non-invasive prenatal testing*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Assisted on a successful claim for an Arrow declaration on behalf of a major pharmaceutical company*

Major media company on the defensive

Arbitration victory for major U.S. pharmaceutical company

Global prosecution and portfolio management for major pharmaceutical company

Prosecuting patents for startup Hutchison Medipharma

Hutchison Medipharma

Advised on a patent revocation action relating to an antiepileptic drug*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.